To demonstrate the presence of E5 protein on cervical lesions, Chang’s group generated antibodies against HPV16 E5 protein and, using cervical biopsies, showed that this antigen was present with high frequency in LSILs (80%) and to a lesser extent in squamous cell carcinoma (SCC) (60%) [26]. Here, ARHGEF15 is linked to squamous cell carcinoma.